Quercetin

Quercetin

SCHEMBL7180221

CCC(=O)O.O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.81
▸ KMT2A Q03164 9/20 0.81
▸ CYP1A2 P05177 8/20 0.81
▸ POLH Q9Y253 7/20 0.81
▸ CYP1A1 P04798 7/20 0.81
▸ CYP1B1 Q16678 7/20 0.81
▸ CYP3A4 P08684 6/20 0.81
▸ KDM4E B2RXH2 6/20 0.81
▸ HSD17B10 Q99714 6/20 0.81
▸ MAPT P10636 6/20 0.81
▸ ABCB1 P08183 6/20 0.81
▸ CYP2C9 P11712 5/20 0.81
▸ RECQL P46063 5/20 0.81
▸ IPMK Q8NFU5 5/20 0.81
▸ IP6K2 Q9UHH9 5/20 0.81
▸ XDH P47989 5/20 0.81
▸ FTO Q9C0B1 5/20 0.81
▸ ALOX15 P16050 4/20 0.81
▸ HIF1A Q16665 4/20 0.81
▸ POLB P06746 4/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quercetin SCHEMBL28881042 0.92 MEN1 (0.83) MEN1KMT2ACYP1A2POLHCYP1A1
Quercetin SCHEMBL14342895 0.91 MEN1 (0.87) MEN1KMT2ACYP1A2POLHCYP1A1
Quercetin SCHEMBL5126185 0.91 MEN1 (0.87) MEN1KMT2ACYP1A2POLHCYP1A1
Quercetin SCHEMBL7186872 0.91 MEN1 (0.87) MEN1KMT2ACYP1A2POLHCYP1A1
Quercetin SCHEMBL28322013 0.91 MEN1 (0.81) MEN1KMT2ACYP1A2POLHCYP1A1
Quercetin SCHEMBL27746111 0.90 MEN1 (0.94) MEN1KMT2ACYP1A2POLHCYP1A1
Quercetin SCHEMBL31507620 0.90 MEN1 (1.00) MEN1KMT2ACYP1A2POLHCYP1A1
Quercetin SCHEMBL29723041 0.90 MEN1 (1.00) MEN1KMT2ACYP1A2POLHCYP1A1
Quercetin SCHEMBL17629824 0.90 MEN1 (1.00) MEN1KMT2ACYP1A2POLHCYP1A1
Quercetin SCHEMBL118425 0.90 MEN1 (1.00) MEN1KMT2ACYP1A2POLHCYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607921-A Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof L'OREAL (FR) 1997-03-04 — — US claimed
WO-2003105806-A1 STABILIZED RETINOL FOR COSMETIC DERMATOLOGICAL, AND PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF SALVONA L.L.C. (US) 2003-12-24 — — WO disclosed
US-20030232091-A1 Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof SHEFER ADI (US) 2003-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232091-A1 Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof RBP4, RBP1, RARA MEN1 4402/4885KMT2A 3495/4885CYP1A2 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback